OSTEOPOROSIS, POSTMENOPAUSAL
Clinical trials for OSTEOPOROSIS, POSTMENOPAUSAL explained in plain language.
Never miss a new study
Get alerted when new OSTEOPOROSIS, POSTMENOPAUSAL trials appear
Sign up with your email to follow new studies for OSTEOPOROSIS, POSTMENOPAUSAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests drug combo to keep bones strong after osteoporosis treatment ends
Disease control OngoingThis study looks at whether the drug zoledronate can prevent bone loss in postmenopausal women who have stopped taking denosumab for osteoporosis. About 200 women who took denosumab for at least two years will receive zoledronate infusions at different times. The goal is to find …
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
New drug combo aims to strengthen bones in elderly women in nursing homes
Disease control OngoingThis study tests whether giving older women (65+) in long-term care a monthly injection of romosozumab for one year, followed by an annual infusion of zoledronic acid, can improve bone density and prevent fractures. The goal is to find a more effective treatment sequence for oste…
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Susan L. Greenspan • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Osteoporosis Exercise-Drug combo study never got off the ground
Knowledge-focused TerminatedThis study aimed to see if adding arm exercises to a bone-strengthening drug could improve bone density in postmenopausal women with osteoporosis. It was designed for women aged 45 and older at high risk of fracture. However, the study was withdrawn before enrolling any participa…
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:04 UTC